Active Penny Stocks in the News
PennyTrader.com presents a range of the hottest penny stocks on the OTC and OTCBB market today. In addition to daily hot stock alerts, PennyTrader.com‘s new penny stock alert service is fast becoming the premier stock alert list to be on.
Subscribe to our FREE penny stock email alert service by visiting http://www.pennytrader.com/sign-up/
Sino Fibre Communications, Inc. (OTCBB:SFBE) reached up 150% in morning trading to $.07 with 1M shares traded. Sino Fibre was founded as a wholesale carrier, to service the international carriers and carriers who require China intercity connectivity. Their major focus is on wholesale IP bandwidth sales to carries and bandwidth aggregators. Sino Fibre Communications, Inc. (OTCBB:SFBE - News) announced that it has closed an acquisition to acquire 50.1% of Europe-China Commercial Union Holdings Ltd "ECL" for US$100 million.
For detailed quote and full article http://www.pennytrader.com/quotes/SFBE.php
Molecular Insight Pharmaceuticals, Inc. (NASDAQ:MIPI) reached up 76.62% in morning trading to $1.36 with 1M shares traded. Molecular Insight Pharmaceuticals is a clinical-stage biopharmaceutical company and pioneer in molecular medicine. The Company is focused on the discovery and development of targeted therapeutic and imaging radiopharmaceuticals for use in oncology. Molecular Insight Pharmaceuticals, Inc. (NASDAQ:MIPI - News), this week presented positive data from Phase 1 clinical studies comparing Trofex™ (123I-MIP-1072), its lead molecular imaging candidate for the diagnosis and monitoring of metastatic prostate cancer, and ProstaScint® (111In-capromab pendetide), an imaging radiopharmaceutical for the visualization of metastatic prostate cancer. Data presented at the Annual Congress of the European Association of Nuclear Medicine in Vienna demonstrated that Trofex rapidly detected prostate cancer localized in the prostate bed, soft tissues and bone within four hours post injection. In contrast, ProstaScint required five days before imaging and was unable to detect metastatic disease in bone.
For detailed quote and full article http://www.pennytrader.com/quotes/MIPI.php
Nexxus Lighting, Inc. (NASDAQ:NEXS) reached up 21.30% in morning trading to $2.62 with 175K shares traded. Nexxus Lighting is a leader in advanced lighting technology, including solid-state LED and fiber optic lighting systems and controls used in commercial, architectural, signage, swimming pool, entertainment and retail lighting. Nexxus Lighting sells its products through its Commercial Lighting, Lumificient and Nexxus Lighting Pool & Spa divisions under the Array™ Lighting, Savi®, eLum™, LiveLED™, Super Vision® and Lumificient™ brand names. Nexxus Lighting, Inc. (NASDAQ:NEXS - News) has received the ENERGY STAR label for its 7.8 watt R30 LED light bulb and is now included on the ENERGY STAR Qualified LED Light Bulbs list.
For detailed quote and full article http://www.pennytrader.com/quotes/NEXS.php
Subscribe to our FREE penny stock email alert service by visiting http://www.pennytrader.com/sign-up/
About PennyTrader.com
PennyTrader.com is a financial and investor relations website committed to covering the microcap market space including Pink Sheets and OTC Bulletin Board and sub-$5 big board stocks. We strive to provide you with the best stocks alerts in the market! We focus on OTCBB, OTC, penny stocks, sub-$5 big board stocks, and timely stocks picks and alerts. Our goal is to inform you of the HOTTEST stocks
in the market before they move. Our staff has years experience in the stock market, and we are confident that you’ll be impressed with the results of our stock picks! If you wish to feature your organization on our website then you can contact us at publisher@pennytrader.com.
Disclosure: PennyTrader.com is not currently being compensated for any stocks covered in this midday report
For complete disclosure information go to http://www.pennytrader.com/disclosure/
PennyTrader.com is not a registered investment advisers or broker/dealer. PennyTrader.com makes no recommendation that the purchase of securities of companies profiled in this press release is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the micro cap companies covered and the potential lack of an active trading market their securities, investing in such securities is highly speculative and carries a high degree of risk. For our full disclaimer go to http://www.pennytrader.com/disclaimer/
